advertisement
Molecular Neurodegeneration 11
Showing records 1 to 11 |
Display all abstracts in Molecular Neurodegeneration94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaRisner ML
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaBelforte N
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaPasini S
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaAgostinone J; Alarcon-Martinez L
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaMcGrady NR
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaVillafranca-Baughman D
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaD'Alessandro KB
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaDotigny F
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaYao V; Cooper ML
Molecular Neurodegeneration 2021; 16: 36
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucomaCueva Vargas JL; Di Polo A
Molecular Neurodegeneration 2021; 16: 43
94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucomaCalkins DJ
Molecular Neurodegeneration 2021; 16: 36
Issue 22-2
Change Issue
advertisement